2006
DOI: 10.1111/j.1743-5013.2006.00029.x
|View full text |Cite
|
Sign up to set email alerts
|

Patent Foramen Ovale: A Primer for Headache Physicians

Abstract: Evidence continues to mount relating the patent foramen ovale (PFO), a small flap-valve in the wall separating the right and left atria of the heart, and number of neurologic syndromes including thromboembolic stroke, migraine headache, and decompression illness in divers. With increasing focus on the migraine relationship, both industry and patients are looking to neurologists for additional information about this cardiac defect. This review will examine the PFO in detail: its role in the fetal circulation, t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2007
2007

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 69 publications
(116 reference statements)
0
1
0
Order By: Relevance
“…Deployment of the BioSTAR device is essentially identical to that of the CardioSEAL and STARFlex devices [25,92,93]. The BioSTAR builds upon this proven delivery technology by incorporating the Rapid Transport™ delivery catheter (as is currently utilized with STARFlex), a newly designed loader (QwikLoad™ Plus) and a custom trans-septal sheath set, which includes a short recovery sheath to simplify implant retrieval, when necessary.…”
Section: Technical Issues Regarding Device Delivery With Biostarmentioning
confidence: 98%
“…Deployment of the BioSTAR device is essentially identical to that of the CardioSEAL and STARFlex devices [25,92,93]. The BioSTAR builds upon this proven delivery technology by incorporating the Rapid Transport™ delivery catheter (as is currently utilized with STARFlex), a newly designed loader (QwikLoad™ Plus) and a custom trans-septal sheath set, which includes a short recovery sheath to simplify implant retrieval, when necessary.…”
Section: Technical Issues Regarding Device Delivery With Biostarmentioning
confidence: 98%